REGN
Regeneron Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$827.72
−1.87%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.01x
- Debt / assets
- 0.05x
- Debt / EBITDA
- 0.35x
- Net debt / EBITDA
- -0.08x
Liquidity & coverage
- Current ratio
- 3.34x
- Quick ratio
- 2.78x
- Cash ratio
- 1.45x
- Interest coverage
- 71.66x
- EBITDA / interest
- 103.79x
- Working capital
- $12.9B
Cash & dividend
- FCF / debt
- 1.77x
- Cash flow / debt
- 2.24x
- Dividend per share
- $3.70
- Dividend yield
- 0.4%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026